These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6216892)

  • 1. Uptake of zimelidine and inhibition of uptake of 5-hydroxytryptamine in the isolated, ventilated and perfused rat lung.
    Post C; Hede AR
    Biochem Pharmacol; 1982 Oct; 31(19):3116-9. PubMed ID: 6216892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of fluoxetine and zimelidine on the uptake of 5-hydroxytryptamine and tryptamine by cortical slices and on responses of cortical neurones to stimulation of the nucleus raphe medianus.
    Jones RS; Broadbent J
    Eur J Pharmacol; 1982 Jul; 81(4):681-5. PubMed ID: 6214414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites.
    Lundström J; Högberg T; Gosztonyi T; de Paulis T
    Arzneimittelforschung; 1981; 31(3):486-94. PubMed ID: 6452883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.
    Ross SB; Hall H; Renyi AL; Westerlund D
    Psychopharmacology (Berl); 1981; 72(3):219-25. PubMed ID: 6164072
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.
    Hall H; Ross S; Ogren SO; Gawell L
    Eur J Pharmacol; 1982 May; 80(2-3):281-2. PubMed ID: 7106185
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.
    Brown D; Scott DH; Scott DB; Meyer M; Westerlund D; Lundström J
    Eur J Clin Pharmacol; 1980 Feb; 17(2):111-6. PubMed ID: 6445274
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake.
    Högberg T; Ulff B; Renyi AL; Ross SB
    J Med Chem; 1981 Dec; 24(12):1499-507. PubMed ID: 6458703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat.
    Fuxe K; Ogren SO; Agnati LF; Eneroth P; Holm AC; Andersson K
    Neurosci Lett; 1981 Jan; 21(1):57-62. PubMed ID: 6259561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine.
    Love BL; Moore RG; Thomas J; Chaturvedi S
    Eur J Clin Pharmacol; 1981; 20(2):135-9. PubMed ID: 6455297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity.
    Holsboer F; Müller OA; Winter K; Doerr HG; Sippell WG
    Psychopharmacology (Berl); 1983; 80(1):85-7. PubMed ID: 6306711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose pharmacokinetic data on zimelidine in depressed patients.
    Montgomery SA; Tiplady B
    Neuropharmacology; 1980 Dec; 19(12):1221-2. PubMed ID: 6449678
    [No Abstract]   [Full Text] [Related]  

  • 14. Zimelidine and clomipramine: different influence on fenfluramine but not p-chloroamphetamine-induced pharmacological effects.
    Pawłowski L; Ruczyńska J; Maj J
    Neurosci Lett; 1980 Feb; 16(2):203-7. PubMed ID: 6221204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake.
    Gebhart GF; Lorens SA
    Br J Pharmacol; 1980 Nov; 70(3):411-4. PubMed ID: 6449224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO; Holm AC
    J Neural Transm; 1980; 47(4):253-71. PubMed ID: 6446594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical effects of zimelidine in man.
    Bertilsson L; Tuck JR; Siwers B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):483-7. PubMed ID: 6450684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.